← FDA Drug Approvals (Drugs@FDA)

BESPONSA

BLA · Biologics License Application · Sponsor: WYETH PHARMS INC · Approved 2017-08-17

Drug application

FDA Application #

BLA761040

Application type

Biologics License Application

Brand name

BESPONSA

Generic name

INOTUZUMAB OZOGAMICIN

Active ingredients

INOTUZUMAB OZOGAMICIN

Dosage form

POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER

Route

—

Marketing status

Prescription

Sponsor

WYETH PHARMS INC

Manufacturer

Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.

First approval

2017-08-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown